An early investigative serum Raman spectroscopy study of meningioma

Serum Raman spectroscopy is explored to classify meningiomas, which are the most frequently reported non-malignant brain and CNS tumors and are often misdiagnosed. We find the technique can be prospectively extended to the screening of high-risk populations and for therapeutic monitoring.